Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic tamsulosin to prevent acute urinary retention after benign anorectal surgery
IRCT20190115042363N1Phase 3Completed
- Sponsor
- Zanjan University of Medical Sciences
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of tamsulosin in hemorrhoid, sponsored by Zanjan University of Medical Sciences. Primary endpoint: Incidence of acute urinary retention. Started Jul 2018; status: completed.
02
Drugs
tamsulosin
03
Conditions
hemorrhoid
Beyond the preview
Go deeper on IRCT20190115042363N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190115042363N1.